Genotype subset selection of multi-UGT1As polymorphisms can predict severe neutropenia and tumour responses of metastatic CRC patients received FOLFIRI regimen

被引:0
|
作者
Hazama, S.
Oka, M.
Hamamoto, Y.
Fujita, Y.
Hinoda, Y. [1 ]
Okayama, N. [1 ]
Okuyama, Y. [2 ]
Kato, T. [3 ]
Mishima, H. [4 ]
Sakamoto, J. [5 ]
机构
[1] Yamaguchi Univ, Grad Sch, Clin Sci Lab, Ube, Yamaguchi 755, Japan
[2] Kyoto First Red Cross Hosp, Kyoto, Japan
[3] Minoh City Hosp, Mino, Japan
[4] Osaka Natl Hosp, Osaka, Japan
[5] Nagoya Univ, Grad Sch Med, Social Life Sci Epidemiol & Clin Res Informat Net, Nagoya, Aichi 4648601, Japan
来源
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词
D O I
10.1016/S1359-6349(09)71201-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:354 / 354
页数:1
相关论文
共 2 条
  • [1] Use of genotype subset selections of multi-UGT1As polymorphisms to predict severe neutropenia and tumor responses of metastatic CRC patients received FOLFIRI regimen
    Hazama, S.
    Okuyama, Y.
    Kato, T.
    Okayama, N.
    Hinoda, Y.
    Sakamoto, J.
    Mishima, H.
    Fujita, Y.
    Hamamoto, Y.
    Oka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [2] UGT1A1*6 IS A PREDICTIVE MARKER OF SEVERE NEUTROPENIA FOR METASTATIC CRC PATIENTS RECEIVED FOLFIRI IN JAPAN
    Hazama, S.
    Okuyama, Y.
    Kato, T.
    Takahashi, K.
    Nozawa, H.
    Okayama, N.
    Hinoda, Y.
    Oka, M.
    Sakamoto, J.
    Mishima, H.
    ANNALS OF ONCOLOGY, 2008, 19 : 138 - 138